Article
Integration of genomic classification and clinical characteristics predicts survival in metastatic prostate cancer
2026-01-13
Abstract excerpt
<h4>Purpose</h4> Tumor comprehensive genomic profiling (CGP) has revolutionized cancer care and identifies patients for biomarker-specific therapy. In metastatic hormone-sensitive prostate cancer (mHSPC), CGP is not currently prognostic and no DNA-based genomic classification exists that accounts for combinations of alterations. We developed a DNA-based CGP classification that is prognostic for overall survival (...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 4bd9b950-cda2-5ef1-b9eb-869fe44a5e9d
- DOI
- 10.64898/2026.01.12.26343673
